Tuesday, October 4, 2011

SciClone to buy back $20 million in stock

SciClone Pharmaceuticals Inc. will repurchase up to $20 million of its outstanding common stock over the next 24 months, the Foster City company said Tuesday.
SciClone’s stock (NASDAQ: SCLN) closed Tuesday at $3.74 per share, up nearly 7.8 percent.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)